Telomerase activity in canine osteosarcoma

Area of Science:

• Veterinary Oncology
• Molecular Biology
• Cancer Research

Background:

• Appendicular osteosarcoma (OSA) is the most common primary bone tumor in dogs.
• Standard treatment (amputation and chemotherapy) offers a poor prognosis, with median survival times around one year.
• Telomere maintenance via telomerase or alternative lengthening of telomeres (ALT) is crucial for tumor development and malignancy.

Purpose of the Study:

• To determine the presence and frequency of telomerase activity in canine osteosarcoma.
• To investigate canine osteosarcoma as a model for human disease and potential therapeutic strategies.

Main Methods:

• Telomeric repeat amplification protocol (TRAP) assay was utilized.
• Analysis was performed on five canine osteosarcoma cell lines.
• Six clinical samples from dogs with appendicular osteosarcoma at amputation were evaluated.

Main Results:

• Telomerase activity was detected in 100% of canine osteosarcoma cell lines.
• Telomerase activity was present in 83% of clinical canine osteosarcoma samples.
• This contrasts with human osteosarcoma, where telomerase expression ranges from 25-40%.

Conclusions:

• Canine osteosarcoma exhibits high telomerase activity, suggesting it is a suitable model for aggressive, telomerase-positive human osteosarcoma.
• The high prevalence of telomerase activity indicates that anti-telomerase therapies may be more effective in treating canine osteosarcoma than in most human patients.